Comparative Evaluation of Intranasal Simvastatin-Loaded Transbilosomes Versus Oral Simvastatin Suspension in Attenuating Heart Failure in Rat Models Induced by Doxorubicin and Ischemia/Reperfusion

Simvastatin (SMS) has profound lipid-independent "pleiotropic" effects that benefit heart failure (HF), but its poor solubility and bioavailability limit its efficacy. This study developed nasal simvastatin-loaded transbilosomes (SLT) to improve drug solubility and bioavailability and mitigate HF. To develop an optimal SLT formulation, the Box-Behnken design was employed. The effectiveness of the nasal SLT was evaluated in vivo using rat models of HF induced by either doxorubicin or ischemia/reperfusion. Relative to free SMS, the optimal SLT achieved a release increase of 3.81-fold, increased bioavailability by 6.35-fold, enhanced permeation by 7.46-fold, and increased the cardiac accumulation by 1.96-fold. Compared to the oral SMS group, the nasal SLT group exhibited significantly lower levels of triglycerides, cholesterol, LDL, CK-MB, LDH, troponin I, NT-proBNP, NO, MDA, and heart rate, being 1.49-fold, 1.47-fold, 1.40-fold, 1.48-fold, 1.42-fold, 1.59-fold, 1.42-fold, 2.0-fold, 1.90-fold, and 1.99-fold lower, respectively. Conversely, HDL, GSH, SOD, ejection fraction, and fractional shortening increased by 1.5-fold, 1.95-fold, 1.48-fold, 1.48-fold, and 1.42-fold, respectively. Histopathology examination validated the efficacy of the nasal SLT formulation. While these findings represent nasal SLT as a promising insight in alleviating HF, future work is recommended to fully elucidate the distinct contribution of isolated vehicle and route controls.

Authors

Institutions

Publication Details

Journal
Journal of drug targeting
Published
2026-11-16
DOI
https://doi.org/10.1080/1061186x.2026.2765322
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comparative Evaluation of Intranasal Simvastatin-Loaded Transbilosomes Versus Oral Simvastatin Suspension in Attenuating Heart Failure in Rat Models Induced by Doxorubicin and Ischemia/Reperfusion

Amany Belal, Maha M. Ghalwash, Rowaedh Ahmed Bawaked, Demiana M. Naguib et al.
Journal of drug targeting
Advanced Drug Delivery Systems
article

Comparative Evaluation of Intranasal Simvastatin-Loaded Transbilosomes Versus Oral Simvastatin Suspension in Attenuating Heart Failure in Rat Models Induced by Doxorubicin and Ischemia/Reperfusion

Amany Belal, Maha M. Ghalwash, Rowaedh Ahmed Bawaked, Demiana M. Naguib, Fahad Hassan Baali, Olfat Yousef Gushgari, Dina M. Mahmoud, Mary Girgis Shahataa, Amr Gamal Fouad, Fadiyah Abdullah Al Shwail, Mariam Rofaiel Wahba Rofaiel
article en

Abstract

Simvastatin (SMS) has profound lipid-independent "pleiotropic" effects that benefit heart failure (HF), but its poor solubility and bioavailability limit its efficacy. This study developed nasal simvastatin-loaded transbilosomes (SLT) to improve drug solubility and bioavailability and mitigate HF. To develop an optimal SLT formulation, the Box-Behnken design was employed. The effectiveness of the nasal SLT was evaluated in vivo using rat models of HF induced by either doxorubicin or ischemia/reperfusion. Relative to free SMS, the optimal SLT achieved a release increase of 3.81-fold, increased bioavailability by 6.35-fold, enhanced permeation by 7.46-fold, and increased the cardiac accumulation by 1.96-fold. Compared to the oral SMS group, the nasal SLT group exhibited significantly lower levels of triglycerides, cholesterol, LDL, CK-MB, LDH, troponin I, NT-proBNP, NO, MDA, and heart rate, being 1.49-fold, 1.47-fold, 1.40-fold, 1.48-fold, 1.42-fold, 1.59-fold, 1.42-fold, 2.0-fold, 1.90-fold, and 1.99-fold lower, respectively. Conversely, HDL, GSH, SOD, ejection fraction, and fractional shortening increased by 1.5-fold, 1.95-fold, 1.48-fold, 1.48-fold, and 1.42-fold, respectively. Histopathology examination validated the efficacy of the nasal SLT formulation. While these findings represent nasal SLT as a promising insight in alleviating HF, future work is recommended to fully elucidate the distinct contribution of isolated vehicle and route controls.

Journal of drug targeting
Beni-Suef University (EG), Saudi Electronic University (SA), Taif University (SA), Nahda University (EG), Modern University for Information and Technology (EG)
Taif University
Good health and well-being
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon